Wedbush Forecasts Geron’s FY2026 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Stock analysts at Wedbush reduced their FY2026 EPS estimates for Geron in a research report issued on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will post earnings of $0.06 per share for the year, down from their prior estimate of $0.07. The […]
Geron Co. (NASDAQ:GERN – Free Report) – Stock analysts at Wedbush reduced their FY2026 EPS estimates for Geron in a research report issued on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will post earnings of $0.06 per share for the year, down from their prior estimate of $0.07. The […]
